Login to Your Account

Pandora's Box to Pharmacopeia

G-Protein Coupled Receptor Signals Are Two-Way Street

By Anette Breindl
Science Editor

Tuesday, April 17, 2012
Almost 50 percent of drugs that are currently on the market target G-protein coupled receptors (GPCRs). But Stuart Maudsley, head of the receptor pharmacology unit at the National Institute of Aging's Laboratory of Neurosciences, thinks that medical research has only scratched the surface of their therapeutic possibilities.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription